Novel insights into the application of recombinant mutated phospholipases D as antigens for developing new strategies against Loxoscelism

• Published in: Acta tropica Vol. 258; p. 107354
• Main Authors: Polli, Nayanne Louise Costacurta, Ferreira, Maria Eduarda de Fraga, Schluga, Pedro Henrique Caires, Antunes, Bruno Cesar, Justa, Hanna Câmara da, Theodoro, João Lucas, Zazula, Matheus Felipe, Naliwaiko, Katya, Minozzo, João Carlos, Senff-Ribeiro, Andrea, Wille, Ana Carolina Martins, Veiga, Silvio Sanches, Gremski, Luiza Helena
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.10.2024
• Subjects: Antivenom; Brown spider; Dermonecrosis; Loxosceles; Toxin; Venom; Toxin; Brown spider; Dermonecrosis; Antivenom; Loxosceles; Venom
• ISSN: 0001-706X; 1873-6254; 1873-6254
• DOI: 10.1016/j.actatropica.2024.107354

•Neutralization of cutaneous and systemic loxoscelism was assessed.•The sphingomyelinase activity of Loxosceles venoms was neutralized.•Number of immunizations optimizes the neutralization, but not the amount of antigens.•Kidney injury was mitigated by immunizations with the tested antigens.•Gaps were addressed to support the implementation of these mutated PLDs as antigens. Loxoscelism is the pathological condition triggered by a brown spider bite. The venom of these spiders is rich in phospholipases D (PLDs), which can induce virtually all local and systemic manifestations. Recombinant mutated PLDs from clinically relevant Loxosceles species in South America have been investigated as potential antigens to develop novel therapeutic strategies for loxoscelism. However, certain gaps need to be addressed before a clinical approach can be implemented. In this study, we examined the potential of these recombinant mutated PLDs as antigens by testing some variations in the immunization scheme. Furthermore, we evaluated the efficacy of the produced antibodies in neutralizing the nephrotoxicity and sphingomyelinase activity of brown spider venoms. Our findings indicate that the number of immunizations has a greater impact on the effectiveness of neutralization compared to the amount of antigen. Specifically, two or three doses were equally effective in reducing dermonecrosis and edema. Additionally, three immunizations proved to be more effective in neutralizing mice lethality than one or two. Moreover, immunizations mitigated the signs of kidney injury, a crucial aspect given that acute renal failure is a serious systemic complication. In vitro inhibition of the sphingomyelinase activity of Loxosceles venoms, a key factor in vivo toxicity, was nearly complete after incubation with antibodies raised against these antigens. These findings underscore the importance of implementing an effective immunization scheme with multiple immunizations, without the need for high antigen doses, and enhances the spectrum of neutralization exhibited by antibodies generated with these antigens. In summary, these results highlight the strong potential of these antigens for the development of new therapeutic strategies against cutaneous and systemic manifestations of loxoscelism. [Display omitted]